Consumer class actions and products to watch for
Class actions can be a way to hold large companies to account when their products fall short of quality standards or pose risks to consumers. Class actions can also be a route to recovery if a manufacturer fails to exercise due diligence in designing or producing their products, makes false …
View the post titled Consumer class actions and products to watch forBanman v Ontario, the preferable procedure requirement, and institutional abuse litigation
The first stage of a class proceeding is the certification stage. Certification is a procedural step, the purpose of which is to screen out cases that are not appropriate to be dealt with on a class-wide basis. In Ontario, an action is certified if it passes the five-step test outlined in se…
View the post titled Banman v Ontario, the preferable procedure requirement, and institutional abuse litigationClass Action pursued for Canadians alleging harms from Ozempic, semaglutide drugs
Ozempic, the popular drug approved in Canada to treat diabetes, has been linked to serious harms to users. Studies have shown a link between the use of semaglutide – the active ingredient in Ozempic – and an increased risk of severe gallbladder-related harms, including gallstones, and gastro…
View the post titled Class Action pursued for Canadians alleging harms from Ozempic, semaglutide drugsOntario Court of Appeal decides non-party litigation funders not liable for defendants’ costs in Davies v. Clarington (Municipality)
In Davies v. Clarington (Municipality), 2023 ONCA 376, the Ontario Court of Appeal reached the reasonable conclusion that non-party lenders with no involvement in directing litigation are not liable to pay an adverse costs award that a plaintiff will not pay. On this appeal, the Court provi…
View the post titled Ontario Court of Appeal decides non-party litigation funders not liable for defendants’ costs in Davies v. Clarington (Municipality)Institutional abuse litigation
Throughout Canada, recent years have seen repeated discoveries of abuse in institutional settings. Allegations against religious organizations, educational facilities, nursing homes, and correctional facilities have brought to light horrific stories of the mistreatment, neglect and abuse of …
View the post titled Institutional abuse litigationCanadians can now claim under $20 million OxyContin class actions settlement
On May 27, 2023, a claims filing process becomes open to Canadians to apply for compensation for injuries suffered from addictions to OxyContin and OxyNEO. The claims process gives Canadian opioid victims the chance to receive funds from a $20 million Settlement to resolve longstanding Oxy…
View the post titled Canadians can now claim under $20 million OxyContin class actions settlementCanadian Invokana / Invokamet Settlement now open to claims
On April 15, 2023, a claims filing process became open to Canadians to apply for compensation for injuries suffered following use of the diabetes medications Invokana, Invokamet and/or Invokamet XR. The claims process will give Canadians the chance to apply to have their claims evaluated pur…
View the post titled Canadian Invokana / Invokamet Settlement now open to claimsBeyond “functional disclosure” – Ontario Court of Appeal applies the rule from Handley Estate in CHU de Québec-Université Laval v. Tree of Knowledge International Corp.
In multi-party litigation, situations may arise where one or more defendants are inclined to settle a plaintiff’s claims while others are not. In these circumstances, the settling defendant may execute a settlement agreement with the plaintiff called a Pierringer agreement. Essentially, Pier…
View the post titled Beyond “functional disclosure” – Ontario Court of Appeal applies the rule from Handley Estate in CHU de Québec-Université Laval v. Tree of Knowledge International Corp.Receive Blog Posts
By subscribing to our blog, you will receive an email when a new post is added. You can unsubscribe at any time by sending an email to us at [email protected] with the word “unsubscribe” in the subject line.